BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 107085)

  • 1. Antilymphocyte globulin in the treatment of a patient with diffuse proliferative lupus nephritis.
    Izzi T; Polchi P; Porcellini A; Mioli V; Lucarelli G
    Haematologica; 1978 Dec; 63(6):689-95. PubMed ID: 107085
    [No Abstract]   [Full Text] [Related]  

  • 2. [Experience with the use of antilymphocytic immunoglobulin in the treatment of systemic lupus erythematosus and rheumatoid arthritis patients].
    Savel'ev AI; Kraskina NA; Nilovskiĭ MN; Shatrova IL; Cherniak VI
    Vopr Revm; 1972; 12(2):27-32. PubMed ID: 5048905
    [No Abstract]   [Full Text] [Related]  

  • 3. [Treatment of systemic lupus and other collagenoses with antilymphocyte globulins. Apropos of 10 cases].
    Herreman G; Broquie G; Metzger JP; Godeau P
    Nouv Presse Med; 1972 Sep; 1(31):2035-9. PubMed ID: 4628759
    [No Abstract]   [Full Text] [Related]  

  • 4. [Study of rosette-forming lymphocytes in peripheral blood of patients with systemic lupus erythematosus].
    Komarov FI; Savel'ev AI; Frumina EI; Pukhal'skiĭ AL; Gutorova NM
    Ter Arkh; 1974; 46(11):78-82. PubMed ID: 4548225
    [No Abstract]   [Full Text] [Related]  

  • 5. The treatment of connective tissue diseases with antilymphocyte globulin.
    Denman AM; Pelton BK; Kinsley M; Knight S; Partridge C; Walker P; Bannister B; Gumpel M; Smith DS; Loewi E
    Postgrad Med J; 1976; 52(5 Suppl):118-22. PubMed ID: 995782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of internal diseases using antilymphocyte globulin].
    Melli G; Mazzei D
    Munch Med Wochenschr; 1970 Mar; 112(12):523-6. PubMed ID: 4911635
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effects of antilymphocytic globulin on the histo-immunological lesions and on the clinical aspect of glomerular nephropathy in adults].
    Vangelista A; Stefoni S; Bonomini V
    Minerva Nefrol; 1973; 20(4):236-42. PubMed ID: 4789743
    [No Abstract]   [Full Text] [Related]  

  • 8. [Treatment of autoimmune diseases].
    Wasastjerna C
    Duodecim; 1973; 89(2):218-26. PubMed ID: 4685136
    [No Abstract]   [Full Text] [Related]  

  • 9. Prolonged remission without treatment after autologous stem cell transplantation for refractory childhood systemic lupus erythematosus.
    Wulffraat NM; Sanders EA; Kamphuis SS; Rijkers GT; Kuis W; Lilien M; Slaper-Cortenbach IC
    Arthritis Rheum; 2001 Mar; 44(3):728-31. PubMed ID: 11263789
    [No Abstract]   [Full Text] [Related]  

  • 10. T lymphocyte subsets and antilymphocyte antibodies in lupus nephritis.
    Patel R; Patel DR; Najera D
    Clin Nephrol; 1986 Aug; 26(2):83-6. PubMed ID: 2944680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunotherapy of autoimmune disease with T cell subset specific antibodies.
    Sriram S; Ranges GE
    Concepts Immunopathol; 1987; 4():275-86. PubMed ID: 3297338
    [No Abstract]   [Full Text] [Related]  

  • 12. [Compatibility of antihuman lymphocyte globulin (AHLG). Possible side effects and complications].
    Preussner S; Frick G; Rudolph W
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1979; 106(1):37-52. PubMed ID: 88389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasmapheresis in the treatment of systemic lupus erythematosus.
    Błaszczyk M; Chorzelski T; Daszyński J; Gaczkowski A; Jabłońska S; Beutner EH
    Arch Immunol Ther Exp (Warsz); 1981; 29(6):769-72. PubMed ID: 6983871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Lymphocytapheresis therapy. 3. Systemic lupus erythematosus].
    Hashimoto H; Tsuda H; Yokoyama S; Yamagata S; Herano T
    Rinsho Ketsueki; 1985 Nov; 26(11):1892-7. PubMed ID: 3835298
    [No Abstract]   [Full Text] [Related]  

  • 15. Chronic plasma exchange in systemic lupus erythematosus nephritis.
    Clark WF; Cattran DC; Balfe JW; Williams W; Lindsay RM; Linton AL
    Proc Eur Dial Transplant Assoc; 1983; 20():629-35. PubMed ID: 6361759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum lactate dehydrogenase and its isozymes in lupus nephritis.
    Inoue T; Okamura M; Amatsu K; Negoro N; Koda S; Kohno M; Takeda T; Kanayama Y
    Arch Intern Med; 1986 Mar; 146(3):548-52. PubMed ID: 3954528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Salsalate-induced pancytopenia in a patient with systemic lupus erythematosus.
    Lisse JR; Lavery JP; Goeken NE
    Ann Allergy; 1993 Mar; 70(3):206-9. PubMed ID: 8452314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Status of plasmapheresis and cyclosporin A in the treatment of systemic lupus erythematosus].
    Graf N; Bambauer R; Jost W; Schäfer M
    Monatsschr Kinderheilkd; 1990 Jul; 138(7):395-8. PubMed ID: 2398909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Study of lupus nephritis: its classification and the significance of subendothelial deposits.
    Tateno S; Kobayashi Y; Shigematsu H; Hiki Y
    Q J Med; 1983; 52(207):311-31. PubMed ID: 6359226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Lymphocytotoxic antibodies in systemic lupus erythematosus: characteristics and relation to the clinicobiological activity of the disease].
    Font J; Martorell J; Cardellach F; Ingelmo M; Sentís J; Vives J; Balcells A
    Med Clin (Barc); 1986 Jun; 87(3):96-100. PubMed ID: 3736231
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.